anidulafungin has been researched along with Cholera Infantum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azanza, JR; Montejo, M | 1 |
| Almirante, B; Pemán, J | 1 |
2 review(s) available for anidulafungin and Cholera Infantum
| Article | Year |
|---|---|
[Pharmacokinetics and pharmacodynamics: interactions and adverse effects. Comparison with other echinocandins].
Topics: Aged; Anidulafungin; Antifungal Agents; Caspofungin; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug Monitoring; Echinocandins; Gastrointestinal Diseases; Half-Life; Humans; Immunosuppressive Agents; Lipopeptides; Liver; Liver Failure; Mycoses; Obesity; Renal Insufficiency; Tissue Distribution | 2008 |
[Current treatment of candidemia. Role of anidulafungin].
Topics: Adult; Aged; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Disease Susceptibility; Double-Blind Method; Drug Resistance, Fungal; Echinocandins; Fluconazole; Fungemia; Gastrointestinal Diseases; Global Health; Humans; Middle Aged; Multicenter Studies as Topic; Neutropenia; Risk Factors; Species Specificity | 2008 |